The ARC-IM delivers targeted therapy which aims to restore movement, according to a news release. The therapy has been used to restore upper extremity movement and function.
Two cases with the implant were completed in Switzerland, the release said. A clinical study is underway to investigatae the safety and effectiveness of thought-initiated spinal cord stimulation in spinal cord injury patients.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.